Enovis Corporation (ENOV)
Enovis Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Wilmington, DE, US. The stock last traded at $18.46, up 1.04% on the session, giving a market capitalisation of $1.06B. On trailing twelve-month figures it carries a trailing P/E of -0.95, a net margin of -48.0%. Its beta of 1.43 implies it has historically moved more than the broad market.
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Enovis Corporation is most often compared with the following Healthcare names: